{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/73fe3ede-5c5c-4850-96a8-30db8dbae8bf/13ea49b6-0877-4eff-87df-508db94e5b3b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Thursday, September 12","description":"<p>Purdue Pharma and its controlling Sackler family members strike a preliminary deal with several US states and local governments to resolve legal claims stemming from the opioid crisis, the FT reports that the Pentagon is compiling a list of companies with ties to the Chinese military and the UK government releases the controversial “Operation Yellowhammer” document that outlines the potential damage from a no-deal Brexit. Plus, the FT’s Philip Stafford explains why investors have given a cold shoulder to Hong Kong Exchanges and Clearing's £32bn bid for the London Stock Exchange. </p>","author_name":"Financial Times"}